Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 147

1.

Genetic Variation in Steroid and Xenobiotic Metabolizing Pathways and Enterolactone Excretion Before and After Flaxseed Intervention in African American and European American Women.

Chang H, Yao S, Tritchler D, Hullar MA, Lampe JW, Thompson LU, McCann SE.

Cancer Epidemiol Biomarkers Prev. 2019 Feb;28(2):265-274. doi: 10.1158/1055-9965.EPI-18-0826.

PMID:
30709839
2.

Effect of Dietary Flaxseed Intake on Circulating Sex Hormone Levels among Postmenopausal Women: A Randomized Controlled Intervention Trial.

Chang VC, Cotterchio M, Boucher BA, Jenkins DJA, Mirea L, McCann SE, Thompson LU.

Nutr Cancer. 2018 Oct 30:1-14. doi: 10.1080/01635581.2018.1516789. [Epub ahead of print]

PMID:
30375890
3.

Omega-3 Polyunsaturated Fatty Acids Time-Dependently Reduce Cell Viability and Oncogenic MicroRNA-21 Expression in Estrogen Receptor-Positive Breast Cancer Cells (MCF-7).

LeMay-Nedjelski L, Mason-Ennis JK, Taibi A, Comelli EM, Thompson LU.

Int J Mol Sci. 2018 Jan 14;19(1). pii: E244. doi: 10.3390/ijms19010244.

4.

Combined optical micromanipulation and interferometric topography (COMMIT).

Sarshar M, Lu T, Anvari B.

Biomed Opt Express. 2016 Mar 18;7(4):1365-74. doi: 10.1364/BOE.7.001365. eCollection 2016 Apr 1.

5.
6.

α-Linolenic Acid Reduces Growth of Both Triple Negative and Luminal Breast Cancer Cells in High and Low Estrogen Environments.

Wiggins AK, Kharotia S, Mason JK, Thompson LU.

Nutr Cancer. 2015;67(6):1001-9. doi: 10.1080/01635581.2015.1053496. Epub 2015 Jul 2.

PMID:
26134471
7.

Growth and gene expression differ over time in alpha-linolenic acid treated breast cancer cells.

Wiggins AK, Mason JK, Thompson LU.

Exp Cell Res. 2015 Apr 10;333(1):147-54. doi: 10.1016/j.yexcr.2015.02.020. Epub 2015 Mar 2.

PMID:
25743093
8.

Flaxseed oil enhances the effectiveness of trastuzumab in reducing the growth of HER2-overexpressing human breast tumors (BT-474).

Mason JK, Fu M, Chen J, Thompson LU.

J Nutr Biochem. 2015 Jan;26(1):16-23. doi: 10.1016/j.jnutbio.2014.08.001. Epub 2014 Sep 22.

PMID:
25441844
9.

17β-estradiol increases liver and serum docosahexaenoic acid in mice fed varying levels of α-linolenic acid.

Mason JK, Kharotia S, Wiggins AK, Kitson AP, Chen J, Bazinet RP, Thompson LU.

Lipids. 2014 Aug;49(8):745-56. doi: 10.1007/s11745-014-3913-8. Epub 2014 Jun 10.

PMID:
24913495
10.

Flaxseed and its lignan and oil components: can they play a role in reducing the risk of and improving the treatment of breast cancer?

Mason JK, Thompson LU.

Appl Physiol Nutr Metab. 2014 Jun;39(6):663-78. doi: 10.1139/apnm-2013-0420. Epub 2013 Dec 23. Review.

PMID:
24869971
11.

Flaxseed enhances the beneficial effect of low-dose estrogen therapy at reducing bone turnover and preserving bone microarchitecture in ovariectomized rats.

Sacco SM, Chen J, Ganss B, Thompson LU, Ward WE.

Appl Physiol Nutr Metab. 2014 Jul;39(7):801-10. doi: 10.1139/apnm-2013-0417. Epub 2014 Jan 16.

PMID:
24844286
12.

A pilot study comparing the effect of flaxseed, aromatase inhibitor, and the combination on breast tumor biomarkers.

McCann SE, Edge SB, Hicks DG, Thompson LU, Morrison CD, Fetterly G, Andrews C, Clark K, Wilton J, Kulkarni S.

Nutr Cancer. 2014;66(4):566-75. doi: 10.1080/01635581.2014.894097. Epub 2014 Mar 26.

13.

Dietary flaxseed-trastuzumab interactive effects on the growth of HER2-overexpressing human breast tumors (BT-474).

Mason JK, Fu MH, Chen J, Yu Z, Thompson LU.

Nutr Cancer. 2013;65(3):451-9. doi: 10.1080/01635581.2013.756921.

PMID:
23530645
14.

Use of isoflavone supplements is associated with reduced postmenopausal breast cancer risk.

Boucher BA, Cotterchio M, Anderson LN, Kreiger N, Kirsh VA, Thompson LU.

Int J Cancer. 2013 Mar 15;132(6):1439-50. doi: 10.1002/ijc.27769. Epub 2012 Sep 18.

15.

Flaxseed does not enhance the estrogenic effect of low-dose estrogen therapy on markers of uterine health in ovariectomized rats.

Sacco SM, Jiang JM, Thompson LU, Ward WE.

J Med Food. 2012 Sep;15(9):846-50. doi: 10.1089/jmf.2011.0314. Epub 2012 Aug 2.

PMID:
22856466
16.

Comparative effects of sesame seed lignan and flaxseed lignan in reducing the growth of human breast tumors (MCF-7) at high levels of circulating estrogen in athymic mice.

Truan JS, Chen JM, Thompson LU.

Nutr Cancer. 2012;64(1):65-71. doi: 10.1080/01635581.2012.630165. Epub 2011 Dec 2.

PMID:
22136581
17.

Dietary intakes of total and specific lignans are associated with clinical breast tumor characteristics.

McCann SE, Hootman KC, Weaver AM, Thompson LU, Morrison C, Hwang H, Edge SB, Ambrosone CB, Horvath PJ, Kulkarni SA.

J Nutr. 2012 Jan;142(1):91-8. doi: 10.3945/jn.111.147264. Epub 2011 Nov 23.

18.

Accessibility of ³H-secoisolariciresinol diglycoside lignan metabolites in skeletal tissue of ovariectomized rats.

Sacco SM, Thompson LU, Ganss B, Ward WE.

J Med Food. 2011 Oct;14(10):1208-14. doi: 10.1089/jmf.2010.0248. Epub 2011 Jun 11.

PMID:
21663478
19.

Effects of flaxseed lignan and oil on bone health of breast-tumor-bearing mice treated with or without tamoxifen.

Chen J, Saggar JK, Ward WE, Thompson LU.

J Toxicol Environ Health A. 2011;74(12):757-68. doi: 10.1080/15287394.2011.567950.

PMID:
21541878
20.

Flaxseed cotyledon fraction reduces tumour growth and sensitises tamoxifen treatment of human breast cancer xenograft (MCF-7) in athymic mice.

Chen J, Saggar JK, Corey P, Thompson LU.

Br J Nutr. 2011 Feb;105(3):339-47. doi: 10.1017/S0007114510003557. Epub 2010 Dec 7.

PMID:
21138602
21.

Effect of maternal and postweaning folic acid supplementation on mammary tumor risk in the offspring.

Ly A, Lee H, Chen J, Sie KK, Renlund R, Medline A, Sohn KJ, Croxford R, Thompson LU, Kim YI.

Cancer Res. 2011 Feb 1;71(3):988-97. doi: 10.1158/0008-5472.CAN-10-2379. Epub 2010 Dec 6.

22.

Flaxseed oil-trastuzumab interaction in breast cancer.

Mason JK, Chen J, Thompson LU.

Food Chem Toxicol. 2010 Aug-Sep;48(8-9):2223-6. doi: 10.1016/j.fct.2010.05.052. Epub 2010 May 24.

PMID:
20580760
23.

The effect of secoisolariciresinol diglucoside and flaxseed oil, alone and in combination, on MCF-7 tumor growth and signaling pathways.

Saggar JK, Chen J, Corey P, Thompson LU.

Nutr Cancer. 2010;62(4):533-42. doi: 10.1080/01635580903532440.

PMID:
20432175
24.

Flaxseed oil reduces the growth of human breast tumors (MCF-7) at high levels of circulating estrogen.

Truan JS, Chen JM, Thompson LU.

Mol Nutr Food Res. 2010 Oct;54(10):1414-21. doi: 10.1002/mnfr.200900521.

PMID:
20425756
25.

Guidance from an NIH workshop on designing, implementing, and reporting clinical studies of soy interventions.

Klein MA, Nahin RL, Messina MJ, Rader JI, Thompson LU, Badger TM, Dwyer JT, Kim YS, Pontzer CH, Starke-Reed PE, Weaver CM.

J Nutr. 2010 Jun;140(6):1192S-1204S. doi: 10.3945/jn.110.121830. Epub 2010 Apr 14.

26.

Prolonged administration of secoisolariciresinol diglycoside increases lignan excretion and alters lignan tissue distribution in adult male and female rats.

Saarinen NM, Thompson LU.

Br J Nutr. 2010 Sep;104(6):833-41. doi: 10.1017/S0007114510001194. Epub 2010 Apr 14.

PMID:
20388250
27.

Flaxseed does not antagonize the effect of ultra-low-dose estrogen therapy on bone mineral density and biomechanical bone strength in ovariectomized rats.

Sacco SM, Jiang JM, Reza-Lopez S, Ma DW, Thompson LU, Ward WE.

J Toxicol Environ Health A. 2009;72(20):1209-16. doi: 10.1080/15287390903127121.

PMID:
20077189
28.

Dietary lignan intakes in relation to survival among women with breast cancer: the Western New York Exposures and Breast Cancer (WEB) Study.

McCann SE, Thompson LU, Nie J, Dorn J, Trevisan M, Shields PG, Ambrosone CB, Edge SB, Li HF, Kasprzak C, Freudenheim JL.

Breast Cancer Res Treat. 2010 Jul;122(1):229-35. doi: 10.1007/s10549-009-0681-x. Epub 2009 Dec 22.

29.

Dietary flaxseed lignan or oil combined with tamoxifen treatment affects MCF-7 tumor growth through estrogen receptor- and growth factor-signaling pathways.

Saggar JK, Chen J, Corey P, Thompson LU.

Mol Nutr Food Res. 2010 Mar;54(3):415-25. doi: 10.1002/mnfr.200900068.

PMID:
19904759
30.

Fatty acids and lignans in unground whole flaxseed and sesame seed are bioavailable but have minimal antioxidant and lipid-lowering effects in postmenopausal women.

Coulman KD, Liu Z, Michaelides J, Quan Hum W, Thompson LU.

Mol Nutr Food Res. 2009 Nov;53(11):1366-75. doi: 10.1002/mnfr.200900032.

PMID:
19824016
31.

Flaxseed and pure secoisolariciresinol diglucoside, but not flaxseed hull, reduce human breast tumor growth (MCF-7) in athymic mice.

Chen J, Saggar JK, Corey P, Thompson LU.

J Nutr. 2009 Nov;139(11):2061-6. doi: 10.3945/jn.109.112508. Epub 2009 Sep 23.

PMID:
19776177
32.

Folic acid supplementation provided in utero and during lactation reduces the number of terminal end buds of the developing mammary glands in the offspring.

Sie KK, Chen J, Sohn KJ, Croxford R, Thompson LU, Kim YI.

Cancer Lett. 2009 Jul 18;280(1):72-7. doi: 10.1016/j.canlet.2009.02.004. Epub 2009 Mar 4.

PMID:
19264391
33.

Flaxseed combined with low-dose estrogen therapy preserves bone tissue in ovariectomized rats.

Sacco SM, Jiang JM, Reza-López S, Ma DW, Thompson LU, Ward WE.

Menopause. 2009 May-Jun;16(3):545-54. doi: 10.1097/gme.0b013e31818fc00a.

PMID:
19182694
34.

Hormone-related supplements and breast cancer risk: need for improved measurement of supplement use.

Boucher BA, Thompson LU, Kreiger N, Cotterchio M.

Int J Cancer. 2008 Nov 15;123(10):2465-6; author reply 2467-8. doi: 10.1002/ijc.23768. No abstract available.

35.

Changes in biomarkers of estrogen receptor and growth factor signaling pathways in MCF-7 tumors after short- and long-term treatment with soy and flaxseed.

Power KA, Chen JM, Saarinen NM, Thompson LU.

J Steroid Biochem Mol Biol. 2008 Nov;112(1-3):13-9. doi: 10.1016/j.jsbmb.2008.07.003. Epub 2008 Jul 25.

PMID:
18703142
36.

Lignans are accessible to human breast cancer xenografts in athymic mice.

Saarinen NM, Power KA, Chen J, Thompson LU.

Nutr Cancer. 2008;60(2):245-50. doi: 10.1080/01635580701649669.

PMID:
18444157
37.

Soy formula and breast cancer risk.

Boucher BA, Cotterchio M, Kreiger N, Thompson LU.

Epidemiology. 2008 Jan;19(1):165-6. No abstract available.

PMID:
18091426
38.
39.

Dietary phytoestrogen intake--lignans and isoflavones--and breast cancer risk (Canada).

Cotterchio M, Boucher BA, Kreiger N, Mills CA, Thompson LU.

Cancer Causes Control. 2008 Apr;19(3):259-72. Epub 2007 Nov 9.

PMID:
17992574
41.
45.

Interaction of sesame seed and tamoxifen on tumor growth and bone health in athymic mice.

Sacco SM, Power KA, Chen J, Ward WE, Thompson LU.

Exp Biol Med (Maywood). 2007 Jun;232(6):754-61.

PMID:
17526767
46.
48.

Blood glucose lowering effects of brown rice in normal and diabetic subjects.

Panlasigui LN, Thompson LU.

Int J Food Sci Nutr. 2006 May-Jun;57(3-4):151-8.

PMID:
17127465
49.

Adolescent dietary phytoestrogen intake and breast cancer risk (Canada).

Thanos J, Cotterchio M, Boucher BA, Kreiger N, Thompson LU.

Cancer Causes Control. 2006 Dec;17(10):1253-61.

PMID:
17111256
50.

Phytoestrogen content of foods consumed in Canada, including isoflavones, lignans, and coumestan.

Thompson LU, Boucher BA, Liu Z, Cotterchio M, Kreiger N.

Nutr Cancer. 2006;54(2):184-201.

PMID:
16898863

Supplemental Content

Loading ...
Support Center